Polyphor, University of Zurich awarded grant to develop new class of LPS-inhibiting antibiotics May 30, 2019
Zynerba initiates phase II trial of Zygel to treat behavioral symptoms in 22q11.2 deletion syndrome May 29, 2019
RSS